Literature DB >> 17223430

Significance of asymmetric basal posterior wall thinning in patients with cardiac Fabry's disease.

Makoto Kawano1, Toshihiro Takenaka, Yutaka Otsuji, Hiroyuki Teraguchi, Shiro Yoshifuku, Toshinori Yuasa, Bo Yu, Masaaki Miyata, Shuichi Hamasaki, Shinichi Minagoe, Yuichi Kanmura, Chuwa Tei.   

Abstract

Although classic Fabry's disease results in multiple causes of death, the cardiac variant of Fabry's disease affects only the cardiac system and results in initial symmetric left ventricular (LV) hypertrophy and later LV dysfunction, asymmetric basal posterior LV wall thinning, restrictive mitral flow, and functional mitral regurgitation with end-stage chronic heart failure (CHF), leading to death. The purpose of this study was to investigate whether these findings predict prognoses in patients with cardiac Fabry's disease. In 13 consecutive men with cardiac Fabry's disease, LV wall thickness, the ejection fraction, mitral E-wave deceleration time, the LV Tei index, and functional mitral regurgitation were measured by echocardiography. Patients were followed for 5 to 96 months (mean 41 +/- 9). Eight patients developed New York Heart Association class III CHF, and 6 experienced cardiac death. A LV Tei index >0.60 and basal posterior LV wall thinning with a ratio of ventricular septal to posterior wall thickness >1.3 significantly preceded CHF and death (Tei index: 4.4 and 5.1 years; posterior wall thinning: 4.0 and 4.7 years), respectively (p <0.05). In conclusion, an increased LV Tei index and asymmetric basal posterior LV wall thinning are important echocardiographic findings that precede CHF and cardiac death in patients with cardiac Fabry's disease.

Entities:  

Mesh:

Year:  2006        PMID: 17223430     DOI: 10.1016/j.amjcard.2006.07.088

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Fabry disease.

Authors:  Toshinori Yuasa; Toshihiro Takenaka; Koji Higuchi; Nami Uchiyama; Yoshihisa Horizoe; Hideto Cyaen; Naoko Mizukami; Kunitsugu Takasaki; Akira Kisanuki; Masaaki Miyata; Mitsuru Ohishi
Journal:  J Echocardiogr       Date:  2017-07-03

Review 2.  Fabry Disease and the Heart: A Comprehensive Review.

Authors:  Olga Azevedo; Filipa Cordeiro; Miguel Fernandes Gago; Gabriel Miltenberger-Miltenyi; Catarina Ferreira; Nuno Sousa; Damião Cunha
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

3.  High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.

Authors:  Nora Seydelmann; Dan Liu; Johannes Krämer; Christiane Drechsler; Kai Hu; Peter Nordbeck; Andreas Schneider; Stefan Störk; Bart Bijnens; Georg Ertl; Christoph Wanner; Frank Weidemann
Journal:  J Am Heart Assoc       Date:  2016-05-31       Impact factor: 5.501

4.  Progression of Left Ventricular Fibrosis in a Woman with Anderson-Fabry Disease: Longitudinal Observations Using Two-Dimensional Speckle-Tracking Echocardiography.

Authors:  Yoshiyuki Takase; Tomoo Nagai; Takao Kubota; Hiroaki Takeo; Motomichi Kosuga; Torayuki Okuyama; Hirotsugu Tabata
Journal:  CASE (Phila)       Date:  2018-02-14

5.  Late-onset Fabry disease revealed by ventricular tachycardia: A case report.

Authors:  Geoffroy Ditac; Kévin Gardey; Antoine Jobbé-Duval; Alain Fouilhoux; Gilles Millat; Philippe Chevalier
Journal:  HeartRhythm Case Rep       Date:  2021-12-03

6.  A case of fabry cardiomyopathy.

Authors:  Jong Chun Nah; Woo-Shik Kim; Wook-Hyun Cho; Suk-Koo Choi; Han-Wook Yoo; Toshihiro Takenaka; Chuwa Tei
Journal:  Korean Circ J       Date:  2009-08-27       Impact factor: 3.243

7.  Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease.

Authors:  Djeven Parameshvara Deva; Kate Hanneman; Qin Li; Ming Yen Ng; Syed Wasim; Chantal Morel; Robert M Iwanochko; Paaladinesh Thavendiranathan; Andrew Michael Crean
Journal:  J Cardiovasc Magn Reson       Date:  2016-03-31       Impact factor: 5.364

Review 8.  Anderson-Fabry disease in heart failure.

Authors:  M M Akhtar; P M Elliott
Journal:  Biophys Rev       Date:  2018-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.